Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
All patients diagnosed with schizophrenia or acute manic or mixed episodes associated with bipolar disorder, with or without psychotic features will be included in the study.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients diagnosed with schizophrenia
You may not be if
Patients who have known hypersensitivity to any ingredient of the product
Patients who have had a recent acute myocardial infarction
Patients who have uncompensated heart failure
Patients who have conditions with a potential to increase QT interval (QT-interval prolongation or history of QT prolongation; congenital long QT syndrome; use with other drugs known to increase the QT interval; arrhythmias treated with class I and III antiarrhythmic drugs)
